Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved methods of HIV vector mediated gene transfer

H Matsuoka1, K Miyake, T Shimada

  • 1Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.

International Journal of Hematology
|July 3, 1998
PubMed
Summary

This study enhances human immunodeficiency virus (HIV) vector gene therapy by concentrating vectors and centrifuging with target cells. This significantly increases vector titer, enabling gene transfer into previously resistant lymphocytes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-2 receptor gamma-chain mutations in severe combined immunodeficiency with B-lymphocytes.

European journal of pediatrics·1996
Same author

Standard RUS skeletal maturation of Tokyo children.

Annals of human biology·1996
Same author

Acute megakaryo-monocytic leukemia with acute myelofibrosis.

American journal of hematology·1996
Same author

MHC class II restriction for T cell proliferative response to mite antigen.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1996
Same author

[Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].

Gan to kagaku ryoho. Cancer & chemotherapy·1996
Same author

[Continuous hepatic arterial infusion chemotherapy with low-dose CDDP plus 5-FU for liver metastases from colorectal carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy·1996

Area of Science:

  • Gene Therapy
  • Viral Vector Technology
  • Immunology

Background:

  • Human immunodeficiency virus (HIV) vectors offer targeted gene transfer into CD4+ cells.
  • Current HIV vector gene therapy applications are limited by low vector titers.
  • Concentration methods are needed to improve HIV vector efficiency.

Purpose of the Study:

  • To develop a high-efficiency strategy for concentrating HIV vectors.
  • To enhance gene transfer into lymphocytes, including those refractory to current vectors.
  • To assess the stability and integration of HIV vectors in target cells.

Main Methods:

  • Concentration of HIV vectors using sulfonated cellulose column chromatography (approx. 20-fold increase).
  • Centrifugation of vector preparations with target cells to increase transduction efficiency (approx. 5-fold increase).

Related Experiment Videos

  • Combination of both methods to achieve a two-order-of-magnitude increase in overall titer.

    • Main Results:

    • Concentrated vector preparations showed no replication-competent cytopathic HIV.
    • Successfully transduced human primary lymphocytes refractory to existing viral vectors.
    • HIV vectors stably integrated into the chromosomes of CD4-enriched human peripheral blood mononuclear cells.

    Conclusions:

    • Combined concentration and centrifugation significantly enhance HIV vector titers.
    • This high-efficiency strategy overcomes previous limitations in transducing lymphocytes.
    • HIV vectors show promise for developing gene therapies targeting lymphocytes.